首页 | 本学科首页   官方微博 | 高级检索  
检索        

剔毒护肝胶囊抗乙型肝炎肝纤维化的临床疗效观察
引用本文:尹华,罗群超,曹瑞娥.剔毒护肝胶囊抗乙型肝炎肝纤维化的临床疗效观察[J].抗感染药学,2004,1(3):125-126.
作者姓名:尹华  罗群超  曹瑞娥
作者单位:广东省韶关市粤北第二人民医院,广东,韶关,512028
基金项目:本课题为2001年韶关市医药卫生科研计划资助项目编号:Y0147
摘    要:目的:探讨剔毒护肝胶囊抗乙型肝炎肝纤维化的临床疗效。方法:对20例剔毒护肝胶囊治疗组患者和15例甘利欣胶囊对照组患者进行对照研究,比较用药前后两组患者肝纤维化血清指标:PC-Ⅲ、LN、HA、IV-C和肝功能指标 ALTTBiI、A/G的变化。结果:剔毒护肝胶囊治疗组患者血清肝纤维化指标,ALT、TBil下降明显,A/G比值上升显著,与甘欣胶囊对照组比较有显著性差异。结论:剔毒护肝胶囊可有效减轻和抑制肝纤维化的发生,明显改善肝功能。

关 键 词:乙型肝炎  肝纤维化  剔毒护肝胶囊  甘利欣胶囊
文章编号:1672-7878(2004)03-0125-02

Therapeutic effect of Tidu Hugan capsule on hepatic fibrosis in patients with hepatitis B
YIN Hua,LUO Qun-chao,CAO Rui-e.Therapeutic effect of Tidu Hugan capsule on hepatic fibrosis in patients with hepatitis B[J].Anti-infection Pharmacy,2004,1(3):125-126.
Authors:YIN Hua  LUO Qun-chao  CAO Rui-e
Abstract:Objective: To observe the therapeutic effect of Tidu Hugan capsule on hepatic fibrosis in patients with hepatitis B. Methods: 35 patients with hepatic fibrosis of hepatitis B were divided into the rapeutic group and control group with randomized method.One group including 20 cases was treated with Tidu Hugan capsule,the other with Diammonium Glycyrrhizinate capsule.After treatment,the indexes of hepatic fibrosis and liver function were detected. Results: PC-Ⅲ,LN,HA,IV-C,ALT and TBil in therapeutic group were obviously decreased and the ratio of A/G was increased. There was significant difference between the two groups(p<0.01 or 0.05). Conclusion: Tidu Hugan capsule is a better medicine to treat hepatic fibrosis.
Keywords:hepatitis B  hepatic fibrosis  Tidu Hugan capsule  Diammonium Olycyrrhizinate capsule
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号